comparemela.com

Latest Breaking News On - Late cycle meeting - Page 4 : comparemela.com

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spero Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Spero Therapeutics, Inc. ("Spero" or the "Company") (NASDAQ: SPRO).

New yorkUnited statesFrance generalTel avivLos angelesAbrahaml pomerantzRoberts willoughbyPrnewswire pomerantzUnited states district courtSecurities exchangeDrug administrationSpero therapeutics incSpero therapeuticsEastern districtSecurities exchange actClass period

SPRO Investor Update: Robbins LLP Reminds Shareholders Lead Plaintiff Deadline in Class Action Against Spero Therapeutics, Inc (SPRO)

SPRO Investor Update: Robbins LLP Reminds Shareholders Lead Plaintiff Deadline in Class Action Against Spero Therapeutics, Inc (SPRO)
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesAaron dumasSecurities exchangeDrug administrationSpero therapeutics incSpero therapeuticsSecurities exchange actTebipenem pivoxil hydrobromideCase aboutLead productNew drug applicationLate cycle meeting

SPRO Investor Update: Robbins LLP Reminds Shareholders Lead

SAN DIEGO, June 11, 2022 (GLOBE NEWSWIRE) The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action.

United statesAaron dumasSecurities exchangeDrug administrationSpero therapeutics incSpero therapeuticsSecurities exchange actTebipenem pivoxil hydrobromideCase aboutLead productNew drug applicationLate cycle meetingRobbins llpPro shareholderPro stockPro class aciton

SPRO Investor Update: Robbins LLP Reminds Shareholders Lead Plaintiff Deadline in Class Action Against Spero Therapeutics, Inc (SPRO) - Press Release

SAN DIEGO, June 11, 2022 (GLOBE NEWSWIRE) The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class act

United statesAaron dumasSecurities exchangeDrug administrationSpero therapeutics incSpero therapeuticsSecurities exchange actTebipenem pivoxil hydrobromideCase aboutLead productNew drug applicationLate cycle meeting

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spero Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Spero Therapeutics, Inc. ("Spero" or the "Company") (NASDAQ: SPRO).

New yorkUnited statesFrance generalTel avivLos angelesAbrahaml pomerantzRoberts willoughbyPrnewswire pomerantzUnited states district courtSecurities exchangeDrug administrationSpero therapeutics incSpero therapeuticsEastern districtSecurities exchange actClass period

vimarsana © 2020. All Rights Reserved.